148 related articles for article (PubMed ID: 32335135)
1. TAT-tagging of VIP exerts positive allosteric modulation of the PAC1 receptor and enhances VIP neuroprotective effect in the MPTP mouse model of Parkinson's disease.
Yu R; Li J; Lin Z; Ouyang Z; Huang X; Reglodi D; Vaudry D
Biochim Biophys Acta Gen Subj; 2020 Aug; 1864(8):129626. PubMed ID: 32335135
[TBL] [Abstract][Full Text] [Related]
2. The allosteric modulation effects of doxycycline, minocycline, and their derivatives on the neuropeptide receptor PAC1-R.
Song S; Wang L; Li J; Huang X; Yu R
Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):627-637. PubMed ID: 31056648
[TBL] [Abstract][Full Text] [Related]
3. Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide.
Atlasz T; Werling D; Song S; Szabo E; Vaczy A; Kovari P; Tamas A; Reglodi D; Yu R
J Mol Neurosci; 2019 Jul; 68(3):397-407. PubMed ID: 30542799
[TBL] [Abstract][Full Text] [Related]
4. Doxycycline exerted neuroprotective activity by enhancing the activation of neuropeptide GPCR PAC1.
Yu R; Zheng L; Cui Y; Zhang H; Ye H
Neuropharmacology; 2016 Apr; 103():1-15. PubMed ID: 26700245
[TBL] [Abstract][Full Text] [Related]
5. A novel small positive allosteric modulator of neuropeptide receptor PAC1-R exerts neuroprotective effects in MPTP mouse Parkinson's disease model.
Fan G; Chen S; Tao Z; Zhang H; Yu R
Acta Biochim Biophys Sin (Shanghai); 2022 Sep; 54(9):1349-1364. PubMed ID: 36082935
[TBL] [Abstract][Full Text] [Related]
6. The functional recombinant first extracellular (EC1) domain of PACAP receptor PAC1 normal form (PAC1-EC1(N)) recognizes selective ligands and stimulates the proliferation of PAC1-CHO cells.
Yu R; Li J; Wang J; Liu X; Huang L; Ding Y; Chen J
Neurosci Lett; 2010 Aug; 480(1):73-7. PubMed ID: 20553998
[TBL] [Abstract][Full Text] [Related]
7. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
[TBL] [Abstract][Full Text] [Related]
8. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
[TBL] [Abstract][Full Text] [Related]
9. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
[TBL] [Abstract][Full Text] [Related]
10. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
11. Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors.
Langer I; Latek D
Front Endocrinol (Lausanne); 2021; 12():711906. PubMed ID: 34867774
[TBL] [Abstract][Full Text] [Related]
12. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
13. Novel peptide VIP-TAT with higher affinity for PAC1 inhibited scopolamine induced amnesia.
Yu R; Yang Y; Cui Z; Zheng L; Zeng Z; Zhang H
Peptides; 2014 Oct; 60():41-50. PubMed ID: 25086267
[TBL] [Abstract][Full Text] [Related]
14. Positive allosteric regulation of PAC1-R up-regulates PAC1-R and its specific ligand PACAP.
Fan G; Tao Z; Chen S; Zhang H; Yu R
Acta Biochim Biophys Sin (Shanghai); 2022 May; 54(5):657-672. PubMed ID: 35593471
[TBL] [Abstract][Full Text] [Related]
15. Novel Small Molecule Positive Allosteric Modulator SPAM1 Triggers the Nuclear Translocation of PAC1-R to Exert Neuroprotective Effects through Neuron-Restrictive Silencer Factor.
Fan G; Chen S; Liang L; Zhang H; Yu R
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555637
[TBL] [Abstract][Full Text] [Related]
16. Characterization of intestinal receptors for VIP and PACAP in rat and in PAC1 receptor knockout mouse.
Ekblad E; Jongsma H; Brabet P; Bockaert J; Sundler F
Ann N Y Acad Sci; 2000; 921():137-47. PubMed ID: 11193817
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons.
Drahushuk K; Connell TD; Higgins D
J Neurosci; 2002 Aug; 22(15):6560-9. PubMed ID: 12151535
[TBL] [Abstract][Full Text] [Related]
18. Identification and functional properties of the pituitary adenylate cyclase activating peptide (PAC1) receptor in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Busto R; Sánchez-Chapado M; Guijarro LG; Prieto JC
Cell Signal; 1999 Nov; 11(11):813-9. PubMed ID: 10617284
[TBL] [Abstract][Full Text] [Related]
19. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells.
Li M; Funahashi H; Mbikay M; Shioda S; Arimura A
Endocrine; 2004 Feb; 23(1):59-75. PubMed ID: 15034198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
